TURINETTO, MARGHERITA
 Distribuzione geografica
Continente #
NA - Nord America 214
EU - Europa 127
AS - Asia 41
AF - Africa 2
OC - Oceania 1
Totale 385
Nazione #
US - Stati Uniti d'America 212
IT - Italia 72
FR - Francia 28
IN - India 13
CN - Cina 10
HK - Hong Kong 6
VN - Vietnam 6
DE - Germania 5
FI - Finlandia 4
GB - Regno Unito 4
NL - Olanda 3
RO - Romania 3
CZ - Repubblica Ceca 2
JP - Giappone 2
MK - Macedonia 2
MX - Messico 2
PH - Filippine 2
SG - Singapore 2
AT - Austria 1
AU - Australia 1
PL - Polonia 1
RU - Federazione Russa 1
UA - Ucraina 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 385
Città #
Columbus 34
Ashburn 19
Fairfield 19
Turin 15
Seattle 13
Santa Cruz 12
Cambridge 9
Rome 9
Woodbridge 9
Houston 8
Patna 8
Ann Arbor 6
Buffalo 5
Dong Ket 5
Torino 5
Council Bluffs 4
Los Angeles 4
Padova 4
Pescara 4
Wilmington 4
Boardman 3
Genoa 3
Lappeenranta 3
Lille 3
Milan 3
San Jose 3
Turda 3
Acapulco de Juárez 2
Amsterdam 2
Borgonovo Val Tidone 2
Cavallino 2
Chieti 2
Gurgaon 2
Hangzhou 2
Hartford 2
Las Vegas 2
Naples 2
New York 2
Pisa 2
Portland 2
Redmond 2
Riva 2
Roccamontepiano 2
San Diego 2
Skopje 2
St Louis 2
Verona 2
Vicenza 2
Ahmedabad 1
Atlanta 1
Austin 1
Bengaluru 1
Bermatingen 1
Cagliari 1
Capriate San Gervasio 1
Cerveteri 1
Chaoyang 1
Chicago 1
Crema 1
East Durham 1
Frankfurt am Main 1
Hefei 1
Helsinki 1
London 1
Mabalacat 1
Medford 1
Muizenberg 1
Paris 1
Pasian di Prato 1
Provo 1
Reston 1
Sacramento 1
San Antonio 1
San Francisco 1
Shanghai 1
Singapore 1
Solihull 1
Southend 1
Suzhou 1
Sydney 1
Wheaton 1
Yellow Springs 1
Totale 293
Nome #
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience, file e27ce430-2b28-2581-e053-d805fe0acbaa 108
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy, file e27ce430-3de5-2581-e053-d805fe0acbaa 87
The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality, file e27ce435-1099-2581-e053-d805fe0acbaa 57
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO Survey, file e27ce435-855a-2581-e053-d805fe0acbaa 29
Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?, file e27ce435-6fd0-2581-e053-d805fe0acbaa 25
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study, file e3009967-8951-4d63-ac33-d2369dd472c6 19
Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report, file 7c224205-7e98-4dfa-80b5-5f8745410fab 18
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers, file e4d8c451-e503-4043-a58b-c8bd8446711a 15
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature, file e27ce435-83c1-2581-e053-d805fe0acbaa 13
Biomarkers of central nervous system involvement from epithelial ovarian cancer, file e27ce434-ce4f-2581-e053-d805fe0acbaa 9
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience, file 8f2258b7-dc9a-4e76-8ba8-6e3673949448 4
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors, file be64f5a3-0826-412c-9a03-2f74dc5a7cb9 3
ASO Visual Abstract: Clinical and Histopathologic Predictors Signaling Recurrence of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers, file a70e325d-eb14-4f04-90bc-359b3e602db8 1
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature, file e27ce431-e586-2581-e053-d805fe0acbaa 1
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society, file e61348dc-dc5a-4282-8e44-1333c59647d7 1
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial, file f0db6949-f933-42dd-aae1-b89ab48ec607 1
Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features, file f6cf104e-22e7-4433-8f90-34c31a3d57c3 1
Totale 392
Categoria #
all - tutte 1.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 9 31 5 5 4 9 3 3 4 2 8
2021/202264 8 1 2 5 4 2 2 6 1 4 17 12
2022/2023101 4 7 20 18 6 14 9 3 5 4 8 3
2023/2024144 3 1 9 7 10 14 13 22 3 25 37 0
Totale 392